Evidence map›Paper›PMID 39704990›Full record

ArticleJournal of nephrology2025

mRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infection.

Guy Rostoker, Stéphanie Rouanet, Myriam Merzoug, Hiba Chakaroun, Mireille Griuncelli, Christelle Loridon, Ghada Boulahia, Luc Gagnon

Abstract readLetter
In one paragraph

Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guy RostokerDepartment of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France. rostotom@orange.fr.ORCID http://orcid.org/0000-0002-4383-3825
Stéphanie RouanetStatEthic, Levallois-Perret, France.
Myriam MerzougDepartment of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France.
Hiba ChakarounInfection Prevention and Control Registered Nurse, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France.
Mireille GriuncelliDepartment of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France.
Christelle LoridonDepartment of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France.
Ghada BoulahiaDepartment of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France.
Luc GagnonIQVIA Laboratories Vaccines, Laval, Canada.

Funding

Ramsay Santé No. COS-RGDS-2021-06-075). Ramsay Santé supported this study for Clinical samples analysis (with support from the Nexelis/Q2 Solutions corporation)Ramsay Santé proofreading in English (with support from the Newmed Publishing corporation)Ramsay Santé Research (GCS Ramsay SantéRamsay Santé statistical analysis (with support from the StatEthic corporation).Ramsay Santé This research was funded by Ramsay Health Cooperation Group for Education
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-spike antibodiesDialysisHealthy controlsNeutralizing antibodiesSARS-CoV-2

Identifiers

PMID39704990
PMCPMC11903638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.